Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|August 27, 2020
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center populationPaola Ghione, Shunan Qi, Brandon S Imber, et al.
Hematology/Oncology and Stem Cell Therapy|September 12, 2025
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative NeoplasmsAndrew D Trunk, Yanwen Chen, Aaron T Gerds, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 17, 2013
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remissionNeha Mehta, Jocelyn C Maragulia, Allison Moskowitz, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma ConferenceAlexey V Danilov, Craig Sauter, Tycel Phillips, et al.
Leukemia & Lymphoma|June 11, 2014
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplantIzaskun Ceberio, Sean M Devlin, Craig Sauter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 14, 2020
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic TransplantationMehdi Hamadani, Manoj Khanal, Kwang W Ahn, et al.
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
The Journal of Molecular Diagnostics : JMD|February 2, 2024
Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation: Comparison of Two Chimerism Test Strategies, Next-Generation Sequencing versus a Combination of Short-Tandem Repeats and Quantitative PCRAiwen Zhang, Stacey Macecevic, Dawn Thomas, et al.
The New England Journal of Medicine|February 1, 2018
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic LeukemiaJae H Park, Isabelle Rivière, Mithat Gonen, et al.
British Journal of Haematology|March 6, 2020
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapyBrandon S Imber, Michel Sadelain, Carl DeSelm, et al.
Pageof 6